Drs. Ambinder, Saji Share Resident Perspectives From the AUA Meeting
By David Ambinder, MD, Akhil Abraham Saji, MD - Last Updated: May 2, 2023David Ambinder, MD, and Akhil Saji, MD, both Urology Residents at New York Medical College/Westchester Medical Center, highlight the importance of attending the AUA meeting as urology residents and some of the research they have found most intriguing.
Drs. Ambinder and Saji are Associate Editors on the GU Oncology Now Advisory Board. They publish review articles and interviews monthly.
View more AUA 2023 meeting coverage, including Dr. Ambinder’s interview with Dr. Kristen Scarpato on Salvage Therapy Options for BCR Prostate Cancer.
Related Posts
One might assume that the AUA meeting is geared toward practicing urologists, but it is also crucial for urologic trainees.
Researchers found 18F-rhPSMA-7.3 to have a high affinity and potential for low bladder activity.
Dr. Wallis interviews Dr. Luckenbaugh on the important research coming out of the AUA meeting pertaining to kidney cancer.
Dr. Ambinder interviews Dr. Scarpato on when focal therapy should be recommended as salvage therapy for BCR prostate cancer.
The relevant updates to the guideline for upper tract urothelial carcinoma are provided by Dr. Peter Clark.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.